A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).
Completed
Vicuron Pharmaceuticals
Phase 2/Phase 3
2002-05-01
The combination of Anidulafungin plus AmBisome® may offer an improved outcome for patients
treated for Invasive Aspergillosis (IA). The purpose of this study is to determine the safety
and the clinical and microbiological effectiveness of anidulafungin plus AmBisome® in treated
patients located in the United States, Europe, and South Africa.
A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).
Completed
Pfizer
Phase 2/Phase 3
2002-05-01
The combination of Anidulafungin plus AmBisome® may offer an improved outcome for patients
treated for Invasive Aspergillosis (IA). The purpose of this study is to determine the safety
and the clinical and microbiological effectiveness of anidulafungin plus AmBisome® in treated
patients located in the United States, Europe, and South Africa.
The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.
Completed
Vicuron Pharmaceuticals
Phase 2
2001-08-01
Anidulafungin may be effective for the treatment of invasive Candida infections. The purpose
of the study is to find the balance between dose tolerance and effectiveness of several doses
for the treatment of United States patients with invasive candidiasis.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
